Ocaliva and Cellulitis - a phase IV clinical study of FDA data

Summary:

Cellulitis is reported as a side effect among people who take Ocaliva (obeticholic acid), especially for people who are female, 60+ old, also take Pantoprazole, and have Dermatitis.

The phase IV clinical study analyzes which people have Cellulitis when taking Ocaliva. It is created by eHealthMe based on reports of 6,917 people who have side effects when taking Ocaliva from the FDA, and is updated regularly.

What is Ocaliva?

Ocaliva has active ingredients of obeticholic acid. eHealthMe is studying from 6,919 Ocaliva users. Check the latest studies of Ocaliva.

What is Cellulitis?

Cellulitis (infection under the skin) is found to be associated with 2,105 drugs and 2,338 conditions by eHealthMe. Check the latest studies of Cellulitis.

On Jul, 15, 2026

6,917 people reported to have side effects when taking Ocaliva.
Among them, 11 people (0.16%) have Cellulitis.

Among these 11 people:

What is the gender of people who have Cellulitis when taking Ocaliva? *

female: 100 %
male: 0.0 %

What is the age of people who have Cellulitis when taking Ocaliva? *

What are other drugs people take besides Ocaliva? *

What are other side effects people have besides Cellulitis? *

Itching: 4 people, 36.36%
Anaemia (lack of blood): 4 people, 36.36%
Pain In Extremity: 4 people, 36.36%
Joint Swelling: 4 people, 36.36%
Wound: 2 people, 18.18%
Gait Disturbance: 2 people, 18.18%
Hypotension (abnormally low blood pressure): 2 people, 18.18%
Hypoglycemia (low blood sugar): 2 people, 18.18%
Hyperbilirubinaemia (excess of bilirubin in the blood): 2 people, 18.18%
Hepatic Failure (liver failure): 2 people, 18.18%

What are the existing conditions these people have? *

Post Procedural Hypothyroidism: 2 people, 18.18%
High Blood Pressure: 2 people, 18.18%
Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 2 people, 18.18%
Type 2 Diabetes: 1 person, 9.09%
Nausea And Vomiting: 1 person, 9.09%
Nausea (feeling of having an urge to vomit): 1 person, 9.09%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 9.09%
Diabetes: 1 person, 9.09%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 1 person, 9.09%
Chest Pain: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Ocaliva and have Cellulitis?

- Check whether Cellulitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ocaliva:

Ocaliva (6,919 reports)

Cellulitis treatments and more:

Cellulitis (75,290 reports)

Browse all side effects of Ocaliva:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cellulitis:

Cellulitis (2,105 drugs)

Browse all the conditions that are associated with Cellulitis:

Cellulitis (2,338 conditions)

Related publications that referenced our studies

Yaylaci S, Yilmaz EU, Guclu E, Kumsar NA, Tamer A, Karabay O, "Clozapine-Induced Febrile Neutropenia and Cellulitis", Turkish journal of emergency medicine, 2014 Mar .
Yaylaci S, Yilmaz EU, Guclu E, Kumsar NA, Tamer A, Karabay O, "Clozapine-Induced Febrile Neutropenia and Cellulitis", Turkish journal of emergency medicine, 2014 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on obeticholic acid (the active ingredients of Ocaliva) and Ocaliva (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.